HIMS · Market open
$28.28
-4.33% today·exchange $28.30
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today
Zacks · 17h ago
Hims & Hers Health Insider Sold Shares Worth $876,846, According to a Recent SEC Filing
MT Newswires · 19h ago
Hims and Hers Is Scaling Rapidly, But Management Needs To Address The Difficult Questions
Insider Monkey · 19h ago
Hims & Hers Just Went Negative on Profit. Twice.
TIKR · 2d ago
Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges
MarketBeat · 3d ago
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
Zacks · 3d ago
Headlines from Yahoo Finance. Not investment advice.